Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
QuidelOrtho Community
NasdaqGS:QDEL Community
3
Narratives
written by author
0
Comments
on narratives written by author
4
Fair Values set
on narratives written by author
Community Investing Ideas
QuidelOrtho
Popular
Undervalued
Overvalued
QuidelOrtho
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Debt And Costs Will Squeeze Margins As Markets Rebound
Key Takeaways Cost pressures and shifting reimbursement trends threaten long-term revenue growth and margin expansion, despite rising global demand for advanced diagnostics and planned operational improvements. Expansion into underpenetrated and emerging markets is challenged by government price controls and aggressive local competition, constraining sustainable revenue and margin gains.
View narrative
US$26.00
FV
0.2% undervalued
intrinsic discount
2.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
QuidelOrtho
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Expanding Access And Aging Demographics Will Redefine Diagnostics
Key Takeaways Accelerated cost-saving actions and structural expansion in recurring revenues are driving margins and earnings higher than consensus expectations. Unique market positioning and upcoming product launches could enable outsized, sustained revenue growth in underserved and rapidly expanding diagnostic segments.
View narrative
US$60.00
FV
56.8% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
6 days ago
author updated this narrative
QuidelOrtho
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Global Expansion And Decentralized Testing Will Unlock Future Potential
Key Takeaways Expansion into global and underpenetrated markets, alongside demographic trends, positions QuidelOrtho for sustained diagnostic demand and stable long-term revenue streams. Operational efficiency, high-value diagnostics innovation, and improved customer satisfaction enhance margins, market share, and resilience against future industry challenges.
View narrative
US$43.14
FV
39.9% undervalued
intrinsic discount
2.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
about 6 hours ago
author updated this narrative
Your Valuation for
QDEL
QDEL
QuidelOrtho
Your Fair Value
US$
Current Price
US$25.95
75.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-2b
3b
2015
2018
2021
2024
2025
2027
2030
Revenue US$3.1b
Earnings US$449.4m
Advanced
Set Fair Value